Published in Nature on March 13, 1980
The in situ cellular immune response in acute herpes simplex encephalitis. Am J Pathol (1986) 1.07
Herpes simplex virus infection of human T-cell subpopulations. Infect Immun (1982) 0.95
Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens. Infect Immun (1983) 0.89
Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J Virol (1994) 0.87
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective. Ann Rheum Dis (1982) 0.75
Effects of immunosuppression on herpes simplex virus growth in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1983) 0.75
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Rational design of peptide-based HIV proteinase inhibitors. Science (1990) 4.57
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Combined biochemical and serological typing of clinical isolates of Klebsiella. Appl Microbiol (1974) 2.55
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J Infect Dis (1996) 2.34
Safety and activity of saquinavir in HIV infection. Lancet (1995) 2.32
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology (1995) 2.29
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Preliminary physiological characterization of temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.11
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Isolation and characterization of temperature-sensitive mutants of vesicular stomatitis virus, New Jersey serotype. J Virol (1971) 1.97
Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase. Antiviral Res (1991) 1.96
Emergence of gentamicin-resistant Klebsiella in a general hospital. Antimicrob Agents Chemother (1977) 1.96
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother (1974) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
O serotyping of Providencia stuartii isolates collected from twelve hospitals. J Clin Microbiol (1979) 1.40
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
A comparative study of 63 strains of ECHO virus type 30. Arch Gesamte Virusforsch (1968) 1.32
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. AIDS (1998) 1.13
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Comparison of bacteriophage typing, serotyping, and biotyping as aids in epidemiological surveillance of Klebsiella infections. J Clin Microbiol (1978) 1.12
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Rapid Laboratory Diagnosis of an Outbreak of Influenza. Can Med Assoc J (1963) 1.04
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. Antimicrob Agents Chemother (1996) 0.98
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
Lincomycin in hospital practice. Can Med Assoc J (1965) 0.93
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1). J Med Chem (1990) 0.91
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
The allocation of specialties to hospitals in a Health District. J Oper Res Soc (1979) 0.90
Antibodies to echovirus type 30 in the Canadian population. Can Med Assoc J (1968) 0.90
2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
Preparation of typing antisera specific for O antigens of Pseudomonas aeruginosa. J Clin Microbiol (1976) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Development of lincomycin resistance by staphylococci. Antimicrob Agents Chemother (Bethesda) (1967) 0.85
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Virology in a general hospital. Can Med Assoc J (1968) 0.85
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides. J Med Chem (1989) 0.83
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82